A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma
- PMID: 19486232
- DOI: 10.1111/j.1468-3083.2009.03295.x
A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma
Abstract
Background: It has been generally believed that the four main causes of melasma are pregnancy, hormonal contraception, family history and sun exposure; however, there are few published comprehensive studies that confirm these assertions. The Pigmentary Disorders Academy - an international group of experts in pigmentary disorders - designed and conducted a global survey of women to investigate the effect of these factors on onset and chronicity of melasma and the course of the disease in order to gain a better understanding of the causative factors associated with this disorder, with a particular focus on hormonal factors and UV exposure in females.
Methods: A 40-item largely self-administered questionnaire was completed by 324 women being treated for melasma in nine clinics worldwide.
Results: The mean age at onset of melasma was 34 years, and 48% of subjects questioned had a family history of melasma (97% in a first-degree relative). Subjects with family history of melasma tended to have darker skin (90% types III-VI) compared to those without (77% types III-VI). The most common time of onset was after pregnancy (42%), often years after the last pregnancy, with 29% appearing pre-pregnancy and 26% during pregnancy. Onset was related to darker skin type post-pregnancy (P = 0.002). Risk of onset during pregnancy was associated with having spent more time outdoors (an extra 10 h per week spent working outside increases the odds of onset of melasma during pregnancy by approximately 27%) and an increased maternal age at pregnancy (increased by approximately 8% for each year of age at first pregnancy; P = 0.02). The odds of melasma occurring for the first time during a pregnancy were also increased with multiple pregnancies (twice the odds if 2 vs. 1 pregnancies, three times higher if 3 or more vs. 1 pregnancy). Of the women, 25% who had used hormonal contraception claimed that melasma appeared for the first time after its use, the rate being higher for those without vs. with a family history.
Conclusions: The results suggest that, whilst accepted causes do affect onset of melasma, a combination of these factors often triggers this disorder. These factors may provide further insights into how physicians can manage individual melasma cases, support recommendation of preventative measures and even anticipate treatment results and recurrence.
Similar articles
-
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.Oncologist. 1996;1(5):326-330. Oncologist. 1996. PMID: 10388011
-
Epidemiology of melasma in Brazilian patients: a multicenter study.Int J Dermatol. 2014 Apr;53(4):440-4. doi: 10.1111/j.1365-4632.2012.05748.x. Epub 2013 Aug 22. Int J Dermatol. 2014. PMID: 23967822
-
Prevalence and awareness of melasma during pregnancy.Int J Dermatol. 2006 Mar;45(3):285-8. doi: 10.1111/j.1365-4632.2004.02470.x. Int J Dermatol. 2006. PMID: 16533230
-
Melasma pathogenesis and influencing factors - an overview of the latest research.J Eur Acad Dermatol Venereol. 2013 Jan;27 Suppl 1:5-6. doi: 10.1111/jdv.12049. J Eur Acad Dermatol Venereol. 2013. PMID: 23205539 Review.
-
Melasma: insights and perspectives.Acta Dermatovenerol Croat. 2010;18(2):124-9. Acta Dermatovenerol Croat. 2010. PMID: 20624364 Review.
Cited by
-
Q-PTP is an optimized technology of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the laser therapy of melasma: A prospective split-face study.Oncol Lett. 2019 Oct;18(4):4136-4143. doi: 10.3892/ol.2019.10743. Epub 2019 Aug 14. Oncol Lett. 2019. PMID: 31516612 Free PMC article.
-
[Melasma : An update on the clinical picture, treatment, and prevention].Hautarzt. 2017 Feb;68(2):120-126. doi: 10.1007/s00105-016-3927-7. Hautarzt. 2017. PMID: 28084498 Review. German.
-
Melasma: an Up-to-Date Comprehensive Review.Dermatol Ther (Heidelb). 2017 Sep;7(3):305-318. doi: 10.1007/s13555-017-0194-1. Epub 2017 Jul 19. Dermatol Ther (Heidelb). 2017. PMID: 28726212 Free PMC article. Review.
-
Application of PRP in Chloasma: A Meta-Analysis and Systematic Review.Comput Intell Neurosci. 2022 Apr 7;2022:7487452. doi: 10.1155/2022/7487452. eCollection 2022. Comput Intell Neurosci. 2022. PMID: 35432505 Free PMC article.
-
Topical Treatments for Melasma and Their Mechanism of Action.J Clin Aesthet Dermatol. 2022 May;15(5):19-28. J Clin Aesthet Dermatol. 2022. PMID: 35642229 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical